A novel series of P1 modified HIV protease inhibitors was synthesized and evaluated for in vitro antiviral activity against wild-type virus and protease inhibitor-resistant viruses. Optimization of the P1 moiety resulted in compounds with femtomolar enzyme activities and cellular antiviral activities in the low nanomolar range culminating in the identification of clinical candidate GW0385.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2006.01.035 | DOI Listing |
Publication Analysis
Top Keywords
hiv protease
8
protease inhibitors
8
ultra-potent modified
4
modified arylsulfonamide
4
arylsulfonamide hiv
4
inhibitors discovery
4
discovery gw0385
4
gw0385 novel
4
novel series
4
series modified
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!